173 related articles for article (PubMed ID: 23067008)
21. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
22. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Szekely L; Pokrovskaja K; Klein G
Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911
[TBL] [Abstract][Full Text] [Related]
25. Gene array identification of Epstein Barr virus-regulated cellular genes in EBV-converted Burkitt lymphoma cell lines.
Baran-Marszak F; Fagard R; Girard B; Camilleri-Broët S; Zeng F; Lenoir GM; Raphaël M; Feuillard J
Lab Invest; 2002 Nov; 82(11):1463-79. PubMed ID: 12429807
[TBL] [Abstract][Full Text] [Related]
26. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
Kelly GL; Long HM; Stylianou J; Thomas WA; Leese A; Bell AI; Bornkamm GW; Mautner J; Rickinson AB; Rowe M
PLoS Pathog; 2009 Mar; 5(3):e1000341. PubMed ID: 19283066
[TBL] [Abstract][Full Text] [Related]
27. EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain.
Maeda A; Kiss C; Chen F; Ehlin-Henriksson B; Nagy N; Szekely L; Takada K; Klein E; Klein G
Int J Cancer; 2001 Sep; 93(5):714-9. PubMed ID: 11477584
[TBL] [Abstract][Full Text] [Related]
28. Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines.
Nagy E; Veress G; Szarka K; Csoma E; Beck Z
Anticancer Res; 2005; 25(3B):2153-60. PubMed ID: 16158958
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.
Nanbo A; Inoue K; Adachi-Takasawa K; Takada K
EMBO J; 2002 Mar; 21(5):954-65. PubMed ID: 11867523
[TBL] [Abstract][Full Text] [Related]
30. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.
Miyauchi K; Urano E; Yoshiyama H; Komano J
Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
[TBL] [Abstract][Full Text] [Related]
32. Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.
Ruf IK; Rhyne PW; Yang H; Borza CM; Hutt-Fletcher LM; Cleveland JL; Sample JT
Mol Cell Biol; 1999 Mar; 19(3):1651-60. PubMed ID: 10022853
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.
Ruf IK; Rhyne PW; Yang C; Cleveland JL; Sample JT
J Virol; 2000 Nov; 74(21):10223-8. PubMed ID: 11024153
[TBL] [Abstract][Full Text] [Related]
34. p62-mediated Selective autophagy endows virus-transformed cells with insusceptibility to DNA damage under oxidative stress.
Wang L; Howell MEA; Sparks-Wallace A; Hawkins C; Nicksic CA; Kohne C; Hall KH; Moorman JP; Yao ZQ; Ning S
PLoS Pathog; 2019 Apr; 15(4):e1007541. PubMed ID: 31017975
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus latency programs dynamically sensitize B cells to ferroptosis.
Burton EM; Voyer J; Gewurz BE
Proc Natl Acad Sci U S A; 2022 Mar; 119(11):e2118300119. PubMed ID: 35275790
[TBL] [Abstract][Full Text] [Related]
36. Non-Random Pattern of Integration for Epstein-Barr Virus with Preference for Gene-Poor Genomic Chromosomal Regions into the Genome of Burkitt Lymphoma Cell Lines.
Janjetovic S; Hinke J; Balachandran S; Akyüz N; Behrmann P; Bokemeyer C; Dierlamm J; Murga Penas EM
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062290
[TBL] [Abstract][Full Text] [Related]
37. l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
Sang W; Tu D; Zhang M; Qin Y; Yin W; Song X; Sun C; Yan D; Wang X; Zeng L; Li Z; Xu K; Xu L
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23117. PubMed ID: 35757978
[TBL] [Abstract][Full Text] [Related]
38. EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Fitzsimmons L; Kelly GL
Viruses; 2017 Nov; 9(11):. PubMed ID: 29137176
[TBL] [Abstract][Full Text] [Related]
39. Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
Jilg W; Voltz R; Markert-Hahn C; Mairhofer H; Münz I; Wolf H
Cancer Res; 1991 Jan; 51(1):27-32. PubMed ID: 1899042
[TBL] [Abstract][Full Text] [Related]
40. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
